Skip to content
Screener

Glaukos GKOS Accounts Payable

Accounts Payable at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$9.22B-2.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.16B+60.1%
Sight Sciences, Inc. logo
Sight Sciences, Inc.SGHT
$1.9M-8.6%
Schering-Plough logo
Schering-PloughSGP
$3.51M+1,045%
Bausch + Lomb logo
Bausch + LombBLCO
$426M-5.1%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$8.03M+73.5%

Other financials

Income statement

See full
Revenue$185.6M+49.5%
Gross profit$151.6M+55.9%
Operating income-$17.3M+23.9%
Net income-$18.4M+6.5%
EPS (diluted)-$0.31+8.8%

Balance sheet

See full
Cash & equivalents$114.5M+13.6%
Total debt$105.9M-1.4%
Total equity$682.5M-10.8%
Total assets$920.5M-6.7%

Cash flow

See full
Operating cash flow$14.8M
CapEx$2.7M+132%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$10.09B+98.7%
Enterprise value$10.08B+98.3%
P/S16.5×+4.7×

Profitability

See full
Gross margin61%-15.4pp
Operating margin-31.6%+22.2pp
Net margin-30.7%+23.3pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26%-11,301pp
Debt / equity0.2×0.0×
Current ratio-0.5×

Where this comes from

Reported directly by Glaukos in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The source filing: Glaukos’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-324201
Line itemJune 30, 2026December 31, 2025
Total assets$920,521$893,487
Liabilities and stockholders' equity
Current liabilities:
Accounts payable$19,139$24,624
Accrued liabilities83,19076,651
Total current liabilities102,329101,275
Operating lease liability35,49135,767
Finance lease liability67,34568,109

Item 1. Financial Statements

FAQ

What is Glaukos's accounts payable?
Glaukos (GKOS) reported accounts payable of $19.14M in Q2 2026.
How has Glaukos's accounts payable changed year-over-year?
Glaukos's accounts payable increased by 39.9% year-over-year, from $13.68M to $19.14M.
What is the long-term trend for Glaukos's accounts payable?
Over 5 years (2020 to 2025), Glaukos's accounts payable has grown at a 41.3% compound annual growth rate (CAGR), from $4.37M to $24.62M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Ask your AI about Glaukos's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude